NCT06567405

Brief Summary

Although orthodontic therapy frequently improves tooth alignment and appearance, its problems with oral hygiene can make patients highly susceptible to gingivitis. After orthodontic treatment, gingivitis is a typical problem. New treatments that promote healing and decrease inflammation are needed. Ascorbic acid and Derma Pen used together have recently surfaced as a potentially effective therapy option for patients who seeking for periodontal therapy during and after orthodontic treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

August 21, 2024

Last Update Submit

May 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • gingival index (GI)

    gingival index will be calibrated using William's probe approximately 1 to 2 mm to the margin of the gingiva at an angulation of 45 degree to document the gingival inflammation signs of the upper six anterior teeth. Each of the four surfaces of the anterior teeth (buccal, lingual, mesial, and distal) will be given a score from 0 to 3 and then areas were added and divided by four to give the accurate GI of each tooth. Score 0 = No signs of inflammation, bleeding, or swelling. Score 1= Presence of signs of mild inflammation, slight edema, and color change but no bleeding. Score 2 = Presence of moderate inflammation, redness, swelling, and bleeding on probing. Score 3 = Presence of severe inflammation, marked redness, edema, and spontaneous bleeding.

    one month

Secondary Outcomes (1)

  • Plaque Index (PI)

    one month

Study Arms (2)

group I: dermapen and topical ascorbic Acid

EXPERIMENTAL

12 individuals who have orthodontically induced gingivitis will be treated with dermapen and topical ascorbic Acid

Device: Derma pen with topical ascorbic Acid

group II: mechanical periodontal treatment

ACTIVE COMPARATOR

12 individuals who have orthodontically induced gingivitis will receive mechanical periodontal treatment only

Procedure: mechanical periodontal treatment

Interventions

Patients will undergo subgingival scaling employing a Piezoelectric ultrasonic scaler to eliminate local factors.

group II: mechanical periodontal treatment

local anesthesia of 2% lignocaine will be administered by infiltration technique in the anterior maxillary region. Microneedling of the mucosa will be performed using dermapen needles, employing an intermittent back-and-forth motion in the anterior maxillary and mandibular region for 30-40 seconds, reaching a depth of 1.5 mm. This will involve the creation of microholes in the gingival tissue using derma pen to enhance the concentration and penetration of the ascorbic Acid through the gingival tissues.

group I: dermapen and topical ascorbic Acid

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients age: 18-25 years .
  • systemically healthy patients.
  • mild to moderate plaque-induced gingivitis patients during orthodontic therapy

You may not qualify if:

  • periodontitis.
  • individuals who smoke or those who have tobacco related habits.
  • partially edentulous individuals.
  • individuals who are diagnosed with drug-induced gingival enlargement.
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Tanta, 6624033, Egypt

Location

MeSH Terms

Conditions

Gingivitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of Orthodontics

Study Record Dates

First Submitted

August 21, 2024

First Posted

August 22, 2024

Study Start

May 30, 2024

Primary Completion

December 1, 2024

Study Completion

February 7, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations